Treatment of anogenital warts in children with topical 0.05% podofilox geland 5% imiquimod cream

A retrospective analysis of 25 infants and young children with anogenital w arts was performed by chart review and telephone interview. Fifteen of 17 p atients treated with podofilox 0.5% gel and 6 of 8 patients treated with im iquimod 5% cream improved or cleared with therapy. Only one patient stopped treatment because of Irritation. Our experience suggests that these agents can be used safely and effectively In young children. Controlled prospecti ve studies should be undertaken to further evaluate the use of podofilox an d imiquimod in the treatment of symptomatic anogenital warts in children.